文献速递主动脉疾病

编辑推荐——近肾及复杂瘤颈腹主动脉瘤开放手术与腔内技术比较:英国COMPlex AneurySm研究(UK-COMPASS)围术期与中期结局

Editor's Choice - Comparison of Open Surgery and Endovascular Techniques for Juxtarenal and Complex Neck Aortic Aneurysms: The UK COMPlex AneurySm Study (UK-COMPASS) - Peri-operative and Midterm Outcomes.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2024-02-29

UK-COMPASS比较了不适合标准腔内修复的近肾及复杂瘤颈腹主动脉瘤患者接受腔内治疗与开放手术的结局。倾向评分调整后围术期死亡率为2.9%,EVAR(1.2%)和FEVAR(2.2%)低于OSR(4.5%);但3.5年随访时FEVAR(27.6%)和EVAR(25.2%)总死亡率高于OSR(14.2%),0-4mm瘤颈亚组总生存相当。

要点

  • 调整后围术期死亡率EVAR 1.2%、FEVAR 2.2%,均低于OSR 4.5%(p=.001)。
  • 3.5年总死亡率FEVAR 27.6%、EVAR 25.2%,高于OSR 14.2%。
  • 0-4mm瘤颈亚组总生存等效,但EVAR和FEVAR再干预更常见。

核心结论

  • 对于近肾动脉瘤(瘤颈0-4mm),FEVAR围术期安全性明显优于OSR,中期生存相当。
  • 对于短瘤颈(5-9mm)和复杂瘤颈(≥10mm)腹主动脉瘤,腔内治疗患者总生存劣于OSR,尽管围术期相对安全。
  • 这需要进一步研究并重新评估当前腔内策略的临床应用,尤其是因合并症和年龄导致总体生存预期较差的患者。

研究设计与样本

  • UK-COMPASS是一项比较性队列研究,比较腔内治疗与开放手术治疗不适合标准标签内EVAR的腹主动脉瘤患者。
  • 研究纳入英格兰2017年11月至2019年10月所有腹主动脉瘤手术,由核心实验室评估AAA解剖,确定围术期风险评分,并使用倾向评分识别适合腔内治疗或OSR的患者。
  • 患者按瘤颈长度(0-4mm、5-9mm或≥10mm)和手术风险分层,最高四分位视为高风险,其余为标准风险。
  • 在8994例患者中,2757例为近肾、短瘤颈或复杂瘤颈形态;倾向评分分层和调整方法比较纳入1916例患者。

主要发现

  • 标准EVAR装置的标签外使用普遍,占患者的35.6%。
  • 调整后围术期死亡率为2.9%,EVAR(1.2%;p=.001)和FEVAR(2.2%;p=.001)低于OSR(4.5%)。
  • 在标准风险且瘤颈0-4mm的患者中,OSR后死亡率为7.4%,FEVAR后为2.3%。
  • 瘤颈长度≥5mm的患者差异较小:OSR 2.1% vs FEVAR 1.0%。
  • 随访3.5年时,整个研究人群总死亡率为20.7%,FEVAR(27.6%)和EVAR(25.2%)高于OSR(14.2%);但在0-4mm瘤颈亚组中,总生存仍等效。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Treatment of juxtarenal and complex neck abdominal aortic aneurysms (AAAs) is now commonly by endovascular rather than open surgical repair (OSR). Published comparisons show poor validity and scientific precision. UK-COMPASS is a comparative cohort study of endovascular treatments vs. OSR for patients with an AAA unsuitable for standard on label endovascular aneurysm repair (EVAR). METHODS: All procedures for AAA in England (November 2017 to October 2019) were identified, AAA anatomy assessed in a Corelab, peri-operative risk scores determined, and propensity scoring used to identify patients suitable for either endovascular treatment or OSR. Patients were stratified by aneurysm neck length (0 - 4 mm, 5 - 9 mm, or ≥ 10 mm) and operative risk; the highest quartile was considered high risk and the remainder standard risk. Death was the primary outcome measure. Endovascular treatments included fenestrated EVAR (FEVAR) and off label standard EVAR (± adjuncts). RESULTS: Among 8 994 patients, 2 757 had AAAs that were juxtarenal, short neck, or complex neck in morphology. Propensity score stratification and adjustment method comparisons included 1 916 patients. Widespread off label use of standard EVAR devices was noted (35.6% of patients). The adjusted peri-operative mortality rate was 2.9%, lower for EVAR (1.2%; p = .001) and FEVAR (2.2%; p = .001) than OSR (4.5%). In standard risk patients with a 0 - 4 mm neck, the mortality rate was 7.4% following OSR and 2.3% following FEVAR. Differences were smaller for patients with a neck length ≥ 5 mm: 2.1% OSR vs. 1.0% FEVAR. At 3.5 years of follow up, the overall mortality rate was 20.7% in the whole study population, higher following FEVAR (27.6%) and EVAR (25.2%) than after OSR (14.2%). However, in the 0 - 4 mm neck subgroup, overall survival remained equivalent. The aneurysm related mortality rate was equivalent between treatments, but re-intervention was more common after EVAR and FEVAR than OSR. CONCLUSION: FEVAR proves notably safer than OSR in the peri-operative period for juxtarenal aneurysms (0 - 4 mm neck length), with comparable midterm survival. For patients with short neck (5 - 9 mm) and complex neck (≥ 10 mm) AAAs, overall survival was worse in endovascularly treated patients compared with OSR despite relative peri-operative safety. This warrants further research and a re-appraisal of the current clinical application of endovascular strategies, particularly in patients with poor general survival outlook owing to comorbidity and age.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Vallabhaneni SR, Patel SR, Campbell B, et al. Editor's Choice - Comparison of Open Surgery and Endovascular Techniques for Juxtarenal and Complex Neck Aortic Aneurysms: The UK COMPlex AneurySm Study (UK-COMPASS) - Peri-operative and Midterm Outcomes. Eur J Vasc Endovasc Surg. 2024. PMID: 38428672. doi:10.1016/j.ejvs.2024.02.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。